Teaching hospital Program year 2025 Source: CMS Open Payments

Childrens Hospital Corporation

MA

CCN 223302 CMS hospital 16246

Open in the dashboard

General payments

$53,061,261

1,831 payments

Research payments

$108,339,081

3,840 payments

Through program year 2025, Childrens Hospital Corporation is reported as receiving $53,061,261 in general payments and $108,339,081 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $12,913,640 232
2025 Research $15,876,505 501
2024 General $13,411,170 251
2024 Research $21,964,313 592
2023 General $6,054,199 262
2023 Research $18,573,389 646
2022 General $3,797,166 274
2022 Research $13,246,118 523
2021 General $6,019,156 268
2021 Research $14,283,900 652
2020 General $5,156,646 250
2020 Research $13,231,933 434
2019 General $5,709,285 294
2019 Research $11,162,922 492

Breakdown

Who paid General payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $32,704,727 59 payments
  2. Shire North American Group Inc $3,292,414 9 payments
  3. Fresenius Kabi USA, LLC $3,240,498 13 payments
  4. Myriad Genetic Laboratories, Inc. $1,498,766 14 payments
  5. Miach Orthopaedics, Inc. $1,452,074 5 payments
  6. Genzyme Corporation $1,206,904 34 payments
  7. AbbVie, Inc. $1,178,575 5 payments
  8. Becton, Dickinson and Company $1,080,534 474 payments
  9. Celgene Corporation $1,008,039 20 payments
  10. Sanofi-Aventis U.S. LLC $762,358 18 payments
  11. Other $5,636,374 1,180 payments
What the payments were for General payments · program years 2019–2025
  1. Royalty or License $44,621,568 918 payments
  2. Grant $2,733,649 122 payments
  3. Charitable Contribution $1,990,866 465 payments
  4. Consulting Fee $1,456,698 12 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,302,836 63 payments
  6. Space rental or facility fees (teaching hospital only) $622,025 97 payments
  7. Education $208,845 34 payments
  8. Debt forgiveness $74,125 75 payments
  9. Gift $19,963 19 payments
  10. Long term medical supply or device loan $18,207 18 payments
  11. Other $12,481 8 payments
Products named General payments · program years 2019–2025
  1. Vonvendi $34,219,927 30 payments
  2. Omegaven Parental Nutrition $2,661,597 9 payments
  3. MyChoice CDx $778,274 10 payments
  4. BRAC CDx $720,492 4 payments
  5. Omegaven Parental Nutrition $578,900 4 payments
  6. Horizon $472,331 163 payments
  7. Thalomid $272,299 7 payments
  8. BD Pharmingen $195,219 83 payments
  9. Monoclonal Antibodies $184,292 1 payment
  10. FACSVia $149,213 59 payments
  11. Other $1,839,465 430 payments

A payment can name more than one product, so these amounts overlap.

1,831 general · 3,840 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record